Publication date: Available online 27 October 2026 Source: The Lancet Infectious Diseases Author(s): Anja Reuter, Lorenzo Guglielmetti, Michael Rich, Paul Sonenthal, Jennifer Furin
Dilemmas in the management of fluoroquinolone-resistant tuberculosis. // The Lancet Infectious Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S1473309926005335?dgcid=rss_sd_all
Dilemmas in the management of fluoroquinolone-resistant tuberculosis. The Lancet Infectious Diseases. https://www.sciencedirect.com/science/article/pii/S1473309926005335?dgcid=rss_sd_all
“Dilemmas in the management of fluoroquinolone-resistant tuberculosis.” The Lancet Infectious Diseases.
@article{article68863,
title = {Dilemmas in the management of fluoroquinolone-resistant tuberculosis},
journal = {The Lancet Infectious Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S1473309926005335?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...